S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
LON:EVG

Evgen Pharma (EVG) Share Price, News & Analysis

GBX 0.78
0.00 (0.00%)
(As of 04/12/2024 ET)
Today's Range
0.77
0.80
50-Day Range
0.75
1.51
52-Week Range
0.70
4.05
Volume
1.65 million shs
Average Volume
1.80 million shs
Market Capitalization
£2.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
EVG stock logo

About Evgen Pharma Stock (LON:EVG)

Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.

EVG Stock Price History

EVG Stock News Headlines

The Next Bitcoin Millionaires
100,000 people became millionaires during Bitcoin’s last bull market. If you missed out… You have a second chance.
The Next Bitcoin Millionaires
100,000 people became millionaires during Bitcoin’s last bull market. If you missed out… You have a second chance.
Evgen Pharma Share Chat
Evgen Pharma Shares Fall on Ending of License Deal
Evgen Pharma Shares Rise on Drug Candidate Data
Market movers: Electricity generators fall on revenue cap reports
See More Headlines
Receive EVG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evgen Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/15/2020
Today
4/14/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
£-3,350,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 0.45 per share
Book Value
GBX 1 per share

Miscellaneous

Free Float
N/A
Market Cap
£2.13 million
Optionable
Not Optionable
Beta
1.47
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Huw Jones BSc (Age 65)
    Ph.D., CEO & Executive Director
    Comp: $304.73k
  • Mr. Toni Haenninen (Age 47)
    CFO & Director
  • Dr. Helen Kuhlman
    Chief Business Officer
  • Dr. Glen Clack FFPM
    M.D., Chief Medical Officer

EVG Stock Analysis - Frequently Asked Questions

How have EVG shares performed in 2024?

Evgen Pharma's stock was trading at GBX 1.60 at the beginning of the year. Since then, EVG shares have decreased by 51.6% and is now trading at GBX 0.78.
View the best growth stocks for 2024 here
.

How were Evgen Pharma's earnings last quarter?

Evgen Pharma plc (LON:EVG) released its earnings results on Monday, June, 15th. The company reported ($2.10) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($2.10).

How do I buy shares of Evgen Pharma?

Shares of EVG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:EVG) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners